Media Releases

2022

16/06/2022

PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests

06/06/2022

Study boosts diagnostic potential for Proteomics – The West Australian

06/06/2022

Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients

02/06/2022

PromarkerD registration submitted to the TGA

12/05/2022

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

12/05/2022

Proteomics International awarded $400,000 to support manufacturing capability in Australia

12/04/2022

New Clinical Advisory Board to support PromarkerD global rollout – Yahoo! Finance

12/04/2022

New Clinical Advisory Board for PromarkerD global rollout

24/03/2022

Indian IP win gives Proteomics massive global cover – The West Australian

24/03/2022

PromarkerD patent granted in India

22/02/2022

Proteomics eyes Medicare for rebate inclusion – The West Australian

22/02/2022

PromarkerD completes ‘pre-assessment’ for Medicare rebate

07/02/2022

Novel biomarkers identified for Asthma and COPD

04/02/2022

Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test – The Sentiment

04/02/2022

Unique panel of biomarkers identified for oesophageal cancer

1
…
7
8
9
10
11
12
13
…
27